Global Tissue Banking Equipment and Consumables Market to Reach $3.8 Billion by 2030
The global market for Tissue Banking Equipment and Consumables estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$3.8 Billion by 2030, growing at a CAGR of 11.6% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 11.1% CAGR and reach US$2.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Equipment segment is readjusted to a revised 12.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $470.3 Million, While China is Forecast to Grow at 10.7% CAGR
The Tissue Banking Equipment and Consumables market in the U.S. is estimated at US$470.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$646.5 Million by the year 2030 trailing a CAGR of 10.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.4% and 9.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.Select Competitors (Total 31 Featured) -
- Beckman Coulter, Inc.
- Biocision, LLC
- BioKryo GmbH
- Biolife Solutions, Inc.
- Bluechiip Ltd.
- Brooks Automation, Inc.
- Chernobyl Tissue Bank
- Cureline, Inc.
- Custom Biogenic Systems, Inc.
- Eppendorf AG
- Hamilton Company
- IMA Pharma
- LifeLink Tissue Bank
- Merck KgaA
- PHC Europe B.V.
- Tata Memorial Hospital - Tissue Bank
- Tecan Group Ltd.
- The PXE International Blood and Tissue Bank
- Thermo Fisher Scientific, Inc.
- TuBaFrost Group
- Versiti
- VWR International LLC
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Beckman Coulter, Inc.
- Biocision, LLC
- BioKryo GmbH
- Biolife Solutions, Inc.
- Bluechiip Ltd.
- Brooks Automation, Inc.
- Chernobyl Tissue Bank
- Cureline, Inc.
- Custom Biogenic Systems, Inc.
- Eppendorf AG
- Hamilton Company
- IMA Pharma
- LifeLink Tissue Bank
- Merck KgaA
- PHC Europe B.V.
- Tata Memorial Hospital - Tissue Bank
- Tecan Group Ltd.
- The PXE International Blood and Tissue Bank
- Thermo Fisher Scientific, Inc.
- TuBaFrost Group
- Versiti
- VWR International LLC
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 189 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 1.6 Billion |
Forecasted Market Value ( USD | $ 3.8 Billion |
Compound Annual Growth Rate | 11.4% |
Regions Covered | Global |